Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
LLY trades against a final fair-value range of $1,025.31-$1,935.83, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
A severe margin compression event driven by aggressive competitor pricing, early regulatory intervention in obesity treatments, and slower-than-expected capacity expansion. This scenario forces reliance on slower-growth legacy assets.
Medicare aggressively negotiates GLP-1 pricing, capping margins and triggering cascading price cuts across commercial channels.
Unforeseen long-term adverse cardiovascular or gastrointestinal events associated with chronic Mounjaro/Zepbound use surface.
Next-generation oral obesity treatments from competitors demonstrate superior efficacy and tolerability, obliterating the injectable market.
Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net incomeNet IncomeNet Income is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions., accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.
Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.
